Table 1
Demographic and clinical data of the patients’ eyes treated with combined trabeculectomy and photodynamic therapy, using BCECF-AM as the photosensitising agent
| Patient No | Age | Sex | Diagnosis | SH | Preop IOP | Preop Meds | OP | Postop IOP | LSL | Postop compl | FU (days) | FU-IOP | Red from preop IOP | Postop Meds |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbreviations; AA = α2 agonist; ACG = angle closure glaucoma; AR = Axenfeld-Rieger-syndrome; B = hyphaema; BB = β blocker; CC = cyclocryocoagulation; CG = congenital glaucoma; CP = cyclophotocoagulation; DPOAG = dysgenetic primary open angle glaucoma; FU = follow up; FU-IOP = intraocular pressure at the latest follow up; H = hypotony; LSL = laser suture lysis; LTP = (argon) laser trabeculoplasty; IOP = intraocular pressure; M = miotic; Meds = medications; OP = date of operation (month/year); PEX = pseudoexfoliation glaucoma; PGA = prostaglandin analogue; PIGG = pigment dispersion glaucoma; POAG = primary open angle glaucoma; postop Compl = postoperative complications; preop IOP = preoperative intraocular pressure; Red from preop IOP = percentage of reduction from preop IOP to latest postop IOP; scar = failure due to scarring; SCI = systemic carboanhydrase inhibitor; SEC = secondary glaucoma; SH = surgical history; TCI = topical carboanhydrase inhibitor; TE = trabeculectomy; TEM = trabeculectomy combined with mitomycin C. | ||||||||||||||
| 1 | 87 | M | SEC | 40 | SCI; BB | 1/99 | 13 | 405 | 18 | −55% | ||||
| 2 | 73 | F | PEX | 20 | SCI; TCI; PGA | 2/99 | 2 | 31 | 18 | TCI; BB; PGA | ||||
| 3 | 20 | M | AR | TE, 2×CC, CP | 30 | SCI; BB; PGA | 1/99 | 16 | 14 | scar | ||||
| 4 | 37 | F | SEC | TO, CC, 4×CP | 45 | SCI; TCI; AA | 1/99 | 14 | 14 | scar | ||||
| 5 | 43 | M | SEC | TE | 24 | AA; BB; M; PGA | 1/99 | 5 | H | 937 | 18 | −25% | ||
| 6 | 84 | M | SEC | TEM | 41 | SCI; BB; M; PGA | 3/99 | 7 | H | 953 | 7 | −83% | ||
| 7 | 82 | F | POAG | CP | 31 | BB | 12/99 | 14 | 60 | 20 | BB | |||
| 8 | 60 | M | POAG | 50 | SCI; BB; M | 3/99 | 9 | 473 | scar | |||||
| 9 | 81 | F | PEX | 2×TE | 40 | SCI; BB; PGA | 4/99 | 17 | 335 | 19 | BB; PGA | |||
| 10 | 82 | F | PEX | 2×TE, CP | 50 | TCI; PGA | 4/99 | 3 | B | 63 | scar | |||
| 11 | 31 | M | POAG | 35 | SCI; PGA | 11/99 | 10 | 144 | 19 | −46% | ||||
| 12 | 84 | F | POAG | 28 | SCI; AA; PGA | 11/99 | 10 | ×1 | 459 | 20 | −29% | |||
| 13 | 69 | F | ACG | TE | 20 | SCI; PGA | 10/99 | 8 | 852 | 12 | −40% | |||
| 14 | 60 | F | DPOAG | LTP, DS | 25 | M; TCI; BB; PGA | 12/99 | 10 | ×1 | 829 | 14 | −44% | ||
| 15 | 24 | F | DPOAG | TE | 38 | SCI | 10/99 | 1 | H+Healon | 850 | 16 | −58% | ||
| 16 | 21 | F | CG | 3×CC | 38 | SCI; AA; PGA | 10/99 | 8 | 56 | scar | ||||
| 17 | 78 | F | PEX | 18 | TCI; BB | 7/00 | 6 | 365 | 14 | TCI | ||||
| 18 | 76 | F | ACG | 26 | SCI; AA; PGA | 1/00 | 12 | ×1 | 670 | 18 | −31% | |||
| 19 | 61 | F | POAG | 2×CP, TE | 50 | AA; PGA | 5/00 | 2 | 469 | 19 | −62% | |||
| 20 | 20 | F | DPOAG | 3×TE, TEM | 52 | SCI | 11/00 | 2 | 21 | scar | ||||
| 21 | 63 | F | POAG | 24 | BB; PGA | 3/00 | 2 | 90 | 13 | BB | ||||
| 22 | 43 | F | SEC | 3×TE, TEM | 26 | SCI; AA; PGA | 1/00 | 6 | 14 | scar | ||||
| 23 | 53 | F | POAG | 1×LTP | 36 | SCI; AA; PGA | 5/00 | 14 | ×1 | 656 | 20 | BB | ||
| 24 | 53 | F | POAG | 30 | SCI; AA; PGA | 7/00 | 10 | ×2 | 608 | 20 | BB | |||
| 25 | 45 | F | POAG | 48 | SCI; BB; AA | 5/00 | 1 | 612 | 17 | −65% | ||||
| 26 | 54 | F | PEX | 35 | SCI; M | 3/00 | 1 | 725 | 19 | −46% | ||||
| 27 | 82 | F | POAG | TE | 25 | TCI; AA; PGA | 10/00 | 12 | ×1 | 504 | 20 | −20% | ||
| 28 | 82 | F | POAG | TE | 32 | TCI; AA; PGA | 1/01 | 4 | ×1 | 172 | scar | |||
| 29 | 74 | F | POAG | TE, LTP | 27 | AA; BB | 9/00 | 8 | ×1 | 485 | 18 | −33% | ||
| 30 | 31 | F | SEC | 42 | SCI | 1/01 | 30 | 30 | scar | |||||
| 31 | 60 | F | DPOAG | 20 | TCI; BB; PGA | 1/01 | 7 | 423 | 18 | −10% | ||||
| 32 | 64 | M | POAG | 27 | SCI | 1/01 | 12 | ×1 | 225 | 18 | −33% | |||
| 33 | 36 | M | SEC | TEM | 31 | SCI; TCI; AA | 12/00 | 7 | 308 | scar | ||||
| 34 | 58 | F | POAG | TE, CP | 19 | TCI; AA; PGA | 1/01 | 18 | 413 | 12 | −37% | |||
| 35 | 58 | F | POAG | CP | 30 | AA; PGA | 3/01 | 3 | 365 | 12 | −60% | |||
| 36 | 60 | M | POAG | TE | 24 | AA; PGA | 5/01 | 12 | 134 | 12 | −50% | |||
| 37 | 66 | M | POAG | 26 | TCI; BB; AA | 1/01 | 5 | ×1 | 159 | 14 | −46% | |||
| 38 | 73 | M | POAG | 30 | TCI; AA; PGA | 5/01 | 10 | 261 | 13 | −57% | ||||
| 39 | 74 | M | POAG | 18 | M; AA; PGA | 2/01 | 5 | ×1 | 517 | 15 | −17% | |||
| 40 | 74 | M | POAG | 28 | M; AA; PGA | 2/01 | 12 | ×1 | 498 | 14 | −50% | |||
| 41 | 38 | M | PDG | 28 | M; BB; PGA | 5/01 | 4 | 407 | 17 | −39% | ||||
| 42 | 75 | M | POAG | 21 | TCI | 10/01 | 17 | 104 | 16 | −24% | ||||
